For clinical laboratories

Inside the assay

What a clinical laboratory professional needs to know about INNOVATIO-ND2, the predictive test based on protein biomarkers.

What kind of assay is it?

A sandwich capture ELISA using highly specific monoclonal antibodies to detect three protein biomarkers (ApoA4, CD5L and IGFBP3) in plasma from patients with type 2 diabetes. Plates are coated with a monoclonal antibody that captures each biomarker.

How long does it take?

The ELISA takes up to 4 hours, including preparation, incubations and standard curves. The report is generated on a web platform available 24/7 that calculates risk from 7 variables. The patient's HDL and eGFR are needed before uploading data, so drawing all samples at the same time is recommended.

Sensitivity and specificity

The current version of the assay has 86% sensitivity and 85% specificity (May 2020 data).

Where is it available?

In Puerto Rico, the English-speaking Caribbean and the U.S. Virgin Islands through Immuno Reference Lab. In the Dominican Republic through Referencia Laboratorio Clínico.

Want to offer it in your country or city?

Write to us to learn about the available business models.

Instructions for use (package insert)

Latest version of the INNOVATIO-ND2 assay, June 2026 (in Spanish).

Download PDF